Response of metastatic breast cancer to trastuzumab?

被引：18
|
作者：
Barnes, DM [1 ]
Miles, DW
机构：
[1] Guys Hosp, Imperial Canc Res Fund, Breast Pathol Lab, London SE1 9RT, England
[2] Guys Hosp, Imperial Canc Res Fund, Breast Biol Grp, London SE1 9RT, England
来源：
LANCET | 2000年 / 355卷 / 9199期
关键词：
D O I：
10.1016/S0140-6736(99)00430-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：160 / 161
页数：2
相关论文
共 50 条
  • [31] Trastuzumab and Vinorelbine combination in the treatment of metastatic breast cancer
    Bayo, J. L.
    Mayordomo, J. I.
    Rovira, P. Sanchez
    Gonzalez, E.
    Bueno, J. M. Garcia
    Ramos, M.
    Crespo, C.
    Illarramendi, J.
    Valerdi, J.
    Palomo, A. Garcia
    EJC SUPPLEMENTS, 2004, 2 (03): : 130 - 130
  • [32] Trastuzumab and lapatinib beyond trastuzumab progression for metastatic breast cancer: strategies and pitfalls
    Brandes, Alba A.
    Franceschi, Enrico
    Tosoni, Alicia
    Degli Esposti, Roberta
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (02) : 179 - 184
  • [33] Neuregulin (NRG) expression modulates clinical response to trastuzumab in patients with metastatic breast cancer (MBC).
    De Alava, E.
    Abad, M.
    Rodriguez, C. A.
    Montero, J. C.
    Serrano, E.
    Ocana, A.
    Torres, A.
    Ruiz, M.
    Cruz, J. J.
    Pandiella, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 557S - 557S
  • [34] Long-time Response with Ado-trastuzumab Emtansine in a Recurrent Metastatic Breast Cancer
    Manthri, Sukesh
    Singal, Sakshi
    Youssef, Bahaaeldin
    Chakraborty, Kanishka
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (10)
  • [35] In situ quantitative measurement of mRNA to predict response to trastuzumab in a cohort of metastatic breast cancer patients
    Vassilakopoulou, Maria
    Bordeaux, Jennifer
    Neumeister, Veronique
    Cheng, Huan
    Schalper, Kurt
    Skarlos, Dimosthenis V.
    Pectasides, Dimitrios G.
    Pavlidis, Nicholas
    Koutras, Angelos
    Linardou, Helena
    Razis, Evangelia
    Bobos, Mattheos
    Kotoula, Vassiliki
    Rimm, David
    Fountzilas, George
    Psyrri, Amanda
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [36] TRASTUZUMAB TREATMENT IN PATIENT WITH BREAST CANCER AND METASTATIC CNS DISEASE
    Perrucci, B.
    Montrone, M.
    Luccarelli, G.
    Lotesoriere, C.
    Nenna, C.
    D'Alessandro, A. R.
    Fanelli, F.
    Pisconti, S.
    CANCER TREATMENT REVIEWS, 2010, 36 : S102 - S102
  • [37] Neutrophil elastase predicts trastuzumab responsiveness in metastatic breast cancer
    Yamashita, JI
    Akizuki, M
    Jotsuka, T
    Harao, M
    Nakano, S
    BREAST JOURNAL, 2006, 12 (03): : 288 - 288
  • [38] Gemcitabine combined with paclitaxel or paclitaxel/trastuzumab in metastatic breast cancer
    Sledge, GW
    SEMINARS IN ONCOLOGY, 2003, 30 (02) : 19 - 21
  • [39] A systematic review of the economic evaluations of trastuzumab in metastatic breast cancer
    Petrou, Panagiotis
    BREAST JOURNAL, 2020, 26 (09): : 1903 - 1905
  • [40] Clinical role of trastuzumab in metastatic breast cancer:: experience of a center
    Menjon-Beltran, S.
    Olivencia, R.
    Gonzalez, E.
    BREAST CANCER RESEARCH, 2007, 9 (01)
12345